Respiratory Devices Market to Reach USD 49.90 Billion by 2033 | North America Holds 38.6% Market Share | Key Players: ResMed, Philips, Medtronic

The global respiratory devices market was valued at USD 25.51 billion in 2025 and is projected to reach USD 49.90 billion by 2033, growing at a CAGR of 8.8% during the forecast period from 2026 to 2033. The market is experiencing strong growth driven by the rising prevalence of chronic respiratory diseases, increasing air pollution levels, growing tobacco consumption in certain regions, and the expanding elderly population worldwide. Respiratory devices play a critical role in the diagnosis, monitoring, and treatment of conditions such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, cystic fibrosis, and other pulmonary disorders. Growing demand for home healthcare solutions, portable respiratory equipment, and advanced patient monitoring systems is significantly contributing to market expansion globally. In addition, increasing healthcare expenditure, improved access to respiratory care services, and ongoing technological advancements are creating substantial long term growth opportunities across both developed and emerging economies. The growing emphasis on early disease detection, continuous patient monitoring, and personalized respiratory care is further accelerating the adoption of advanced respiratory technologies across healthcare settings.

The market is also benefiting from continuous innovation in smart inhalers, portable oxygen concentrators, ventilators, nebulizers, and sleep apnea management devices aimed at enhancing treatment effectiveness and patient convenience. Several strategic investments, product launches, and capacity expansion initiatives are reshaping the industry landscape. Leading companies including ResMed Inc., Philips Respironics, Medtronic plc, Fisher & Paykel Healthcare, and GE HealthCare are actively investing in digital respiratory care platforms, connected monitoring systems, and next generation ventilation technologies to strengthen their market position. Increasing adoption of telehealth enabled respiratory care, artificial intelligence driven diagnostics, and home based treatment solutions is expected to support long term market expansion, while rising healthcare investments and growing awareness of respiratory health continue to create new opportunities across the global respiratory devices market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/respiratory-devices-market?sai-v

Key Developments

April 2026: The United States increased investments in respiratory care infrastructure and advanced pulmonary treatment technologies, supporting growing demand for respiratory devices across hospitals, clinics, and home healthcare settings.

March 2026: Japan strengthened healthcare modernization initiatives and expanded adoption of advanced respiratory monitoring and therapeutic devices to address the rising prevalence of chronic respiratory disorders and aging populations.

February 2026: ResMed Inc. expanded innovation efforts in connected respiratory care solutions, enhancing remote patient monitoring capabilities and improving management of sleep apnea and chronic respiratory conditions.

January 2026: Healthcare providers increased investments in home-based respiratory care equipment, supporting greater adoption of portable ventilators, oxygen concentrators, and respiratory monitoring systems.

December 2025: Medical device manufacturers accelerated development of AI-enabled respiratory monitoring technologies, improving diagnostic accuracy, treatment optimization, and patient outcomes.

November 2025: Philips Healthcare strengthened its respiratory care portfolio through advancements in ventilation, sleep therapy, and patient monitoring solutions for acute and chronic respiratory conditions.

October 2025: Industry participants expanded production capacities for respiratory devices to address increasing global demand driven by respiratory disease prevalence, aging populations, and rising healthcare expenditures.

September 2025: India increased investments in critical care and respiratory healthcare infrastructure, supporting wider accessibility of ventilators, nebulizers, oxygen therapy devices, and pulmonary diagnostic equipment.

July 2025: Medtronic plc advanced respiratory care innovation through enhanced ventilation systems and patient monitoring technologies designed to improve clinical outcomes.

May 2025: Healthcare organizations accelerated adoption of telehealth-integrated respiratory devices, enabling remote monitoring and management of patients with chronic obstructive pulmonary disease (COPD), asthma, and sleep-related breathing disorders.

March 2025: Strategic collaborations between healthcare providers and medical device manufacturers expanded development of next-generation respiratory care solutions focused on portability, connectivity, and personalized treatment.

January 2025: Governments across North America, Europe, and Asia-Pacific increased investments in healthcare infrastructure and respiratory disease management programs, supporting long-term growth and innovation within the respiratory devices market.

Key Players

ResMed | Koninklijke Philips N.V. | Medtronic | Fisher & Paykel Healthcare Limited | Drägerwerk AG & Co. KGaA | Getinge | Masimo | Baxter | Invacare International Holdings Corp. | CorVent Medical Inc. | AstraZeneca | Others

Key Highlights

ResMed - Holds a 13.4% share, driven by its global leadership in sleep apnea and respiratory care devices, strong connected healthcare ecosystem, and extensive distribution network.

Koninklijke Philips N.V. - Holds a 11.8% share, supported by a comprehensive respiratory care portfolio, advanced patient monitoring technologies, and a strong presence across hospitals and home healthcare settings.

Medtronic - Holds a 10.6% share, strengthened by innovative ventilators, respiratory monitoring solutions, and broad critical care capabilities serving healthcare providers worldwide.

Fisher & Paykel Healthcare Limited - Holds a 9.2% share, fueled by its expertise in humidification systems, non-invasive ventilation technologies, and growing adoption in respiratory therapy applications.

Drägerwerk AG & Co. KGaA - Holds a 8.1% share, supported by advanced ventilation systems, critical care solutions, and a long-standing presence in intensive care and emergency medicine.

Getinge - Holds a 7.0% share, driven by its critical care product portfolio, advanced ventilator technologies, and strong relationships with hospitals and healthcare institutions.

Masimo - Holds a 6.1% share, strengthened by innovative respiratory monitoring solutions, pulse oximetry technologies, and increasing demand for patient monitoring systems.

Baxter - Holds a 5.6% share, supported by its broad healthcare product portfolio, respiratory therapy offerings, and strong global healthcare infrastructure.

Invacare International Holdings Corp. - Holds a 4.8% share, fueled by a diverse range of home respiratory care products, oxygen therapy equipment, and mobility healthcare solutions.

CorVent Medical Inc. - Holds a 3.4% share, driven by specialized ventilator technologies, innovative respiratory support systems, and expanding adoption in critical care environments.

AstraZeneca - Holds a 2.9% share, supported by its strong respiratory disease franchise, strategic investments in respiratory care solutions, and growing focus on integrated patient management.

Others - Hold a combined 17.1% share, comprising regional respiratory device manufacturers, specialized ventilation companies, monitoring solution providers, and emerging healthcare technology firms.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=respiratory-devices-market?sai-v

Market Drivers

Increasing prevalence of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and respiratory infections is significantly driving growth of the respiratory devices market worldwide.

Growing aging population and rising incidence of age-related respiratory disorders are accelerating demand for advanced respiratory monitoring and therapeutic devices globally.

Increasing air pollution levels, occupational exposure to harmful substances, and smoking-related health complications are strengthening adoption of respiratory care solutions across healthcare settings.

Rising demand for home healthcare services and remote patient monitoring is contributing to rapid commercialization of portable and user-friendly respiratory devices.

Expansion of intensive care units, emergency care facilities, and critical care infrastructure is improving utilization of ventilators, oxygen delivery systems, and respiratory monitoring equipment.

Growing investments in healthcare infrastructure, respiratory disease management programs, and advanced medical technologies are supporting market expansion across developed and emerging economies.

Continuous advancements in respiratory diagnostics, non-invasive ventilation technologies, smart inhalers, and connected healthcare devices are improving patient outcomes and treatment efficiency.

Increasing awareness regarding early diagnosis, disease management, and preventive respiratory care is further propelling global respiratory devices market growth.

Industry Developments

Rapid advancement in smart respiratory devices and digital health technologies improving patient monitoring, treatment adherence, and real-time disease management capabilities.

Increasing adoption of portable oxygen concentrators, home ventilators, and wireless respiratory monitoring systems supporting the shift toward home-based healthcare.

Growing investments in artificial intelligence, cloud-connected healthcare platforms, and telemedicine integration accelerating innovation across the respiratory care ecosystem.

Expansion of respiratory diagnostic technologies and advanced pulmonary function testing systems improving early detection and clinical decision-making.

Rising collaborations among medical device manufacturers, healthcare providers, research institutions, and technology companies driving development of next-generation respiratory solutions.

Strategic product launches, regulatory approvals, and manufacturing capacity expansions supporting global market expansion and wider patient access.

Continuous innovation in non-invasive ventilation systems, aerosol drug delivery devices, oxygen therapy equipment, and respiratory monitoring technologies improving treatment effectiveness and patient comfort.

Regional Insights

North America 38.6% share: "Leads the market due to advanced healthcare infrastructure, high prevalence of respiratory diseases, strong adoption of innovative medical technologies, and significant healthcare expenditure across the United States and Canada."

Europe 27.4% share: "Growth supported by aging populations, increasing respiratory disease burden, favorable reimbursement policies, and strong investments in healthcare modernization and respiratory care services."

Asia Pacific 25.8% share: "Rapid expansion driven by growing healthcare infrastructure, rising air pollution levels, increasing healthcare awareness, large patient populations, and expanding access to respiratory treatment solutions across China, Japan, India, and South Korea."

Latin America 4.5% share: "Growth supported by improving healthcare access, rising incidence of respiratory disorders, expanding hospital infrastructure, and increasing adoption of advanced respiratory care technologies."

Middle East & Africa 3.7% share: "Gradual growth driven by healthcare infrastructure development, increasing investments in medical technologies, rising awareness of respiratory health, and expanding access to critical care services."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/respiratory-devices-market?sai-v

Key Segments
➥ By Product Type

Therapeutic Devices: Represents the dominant segment, driven by the widespread use of ventilators, oxygen concentrators, nebulizers, CPAP devices, and other respiratory support systems for treating chronic and acute respiratory conditions.

Monitoring Devices: Represents a significant segment, supported by increasing demand for pulse oximeters, capnography systems, and respiratory monitoring solutions for continuous patient assessment and disease management.

Diagnostic Devices: Represents a major segment, fueled by growing utilization of spirometers, pulmonary function testing equipment, and imaging technologies for early diagnosis and monitoring of respiratory disorders.

Consumables & Accessories: Represents a substantial segment, driven by recurring demand for masks, tubing, filters, nasal cannulas, breathing circuits, and other disposable respiratory care products.

Others: Represents a moderate segment, supported by the adoption of emerging respiratory technologies and specialized devices designed for specific clinical applications.

➥ By Application/Indication

Chronic Obstructive Pulmonary Disease (COPD): Represents the dominant segment, driven by the rising global prevalence of COPD and the growing need for long-term respiratory care and disease management solutions.

Asthma: Represents a significant segment, supported by increasing incidence of asthma and growing adoption of inhalation therapy and respiratory monitoring devices.

Sleep Apnea: Represents a major segment, fueled by rising awareness, improved diagnosis rates, and increasing use of CPAP and BiPAP devices for sleep-related breathing disorders.

Pneumonia: Represents a substantial segment, driven by the demand for respiratory support and oxygen therapy in hospitalized and critically ill patients.

Cystic Fibrosis: Represents a specialized segment, supported by increasing utilization of airway clearance systems, nebulizers, and advanced respiratory therapies.

Bronchitis: Represents a growing segment, fueled by rising respiratory infections and increasing demand for therapeutic and monitoring devices to manage symptoms and improve patient outcomes.

Others: Represents a moderate segment, supported by expanding applications in respiratory distress syndrome, pulmonary fibrosis, lung cancer, and other respiratory conditions.

➥ By Portability

Stationary Devices: Represents the dominant segment, driven by extensive deployment of respiratory equipment in hospitals, intensive care units, and long-term healthcare facilities.

Portable Devices: Represents a rapidly growing segment, supported by increasing demand for home-based care, patient mobility, remote monitoring, and advancements in compact respiratory technologies.

➥ By End User

Hospitals: Represents the dominant segment, driven by high patient volumes, advanced respiratory care infrastructure, and extensive use of therapeutic, diagnostic, and monitoring devices.

Homecare Settings: Represents a significant and rapidly growing segment, fueled by increasing preference for home-based treatment, aging populations, and advancements in portable respiratory devices.

Ambulatory Surgical Centers (ASCs): Represents a substantial segment, supported by rising outpatient procedures and growing adoption of respiratory monitoring and support equipment.

Clinics: Represents a major segment, driven by increasing diagnosis and management of chronic respiratory diseases in outpatient healthcare settings.

Emergency Medical Services (EMS)/Transport: Represents a growing segment, fueled by the need for portable respiratory support systems and monitoring devices during emergency response and patient transportation.

Others: Represents a moderate segment, supported by utilization across rehabilitation centers, long-term care facilities, military healthcare services, and specialty respiratory treatment centers.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.